DEVON PATTILLO: Open Payments
NPI 1760892616 · SNELLVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,293 in 159 payments from 19 companies in 2025. Trend: 2023 $8,543 · 2024 $4,273 · 2025 $3,293
Food & beverage: $3,293
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $641 |
| UCB, Inc. | 20 | $520 |
| GENZYME CORPORATION | 9 | $326 |
| Novartis Pharmaceuticals Corporation | 13 | $313 |
| PFIZER INC. | 16 | $307 |
| Galderma Laboratories, L.P. | 12 | $173 |
| LEO Pharma Inc. | 6 | $165 |
| Regeneron Healthcare Solutions, Inc. | 7 | $156 |
| Incyte Corporation | 7 | $151 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $140 |
Products named: Bimzelx, DUPIXENT, RINVOQ, SKYRIZI, CIBINQO, COSENTYX, OPZELURA, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
